University of North Carolina Chapel Hill — Chapel Hill, North Carolina

University of North Carolina Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27278.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

University of North Carolina Chapel Hill has participated in 64 clinical trials with 19 currently active.

Therapeutic areas: Non-muscle Invasive Bladder Cancer, Fetal Structural Anomalies, Barrett's Esophagus.

Sponsors: ImmunityBio, Inc., Columbia University, University of North Carolina, Chapel Hill.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of North Carolina Chapel Hill?

University of North Carolina Chapel Hill has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of North Carolina Chapel Hill conducted?

University of North Carolina Chapel Hill has 64 clinical trials on record, with 19 currently active. Their work covers Non-muscle Invasive Bladder Cancer, Fetal Structural Anomalies, Barrett's Esophagus.

Is University of North Carolina Chapel Hill accredited by Crixeo Health?

Yes — University of North Carolina Chapel Hill holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of North Carolina Chapel Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.